Celltrion
Incheon · Founded 2002
About Celltrion
Celltrion Inc is a Korea-based company principally engaged in the research, development, and manufacture of therapeutic proteins. The company mainly manufactures biosimilar products, which are used to treat breast cancer, rheumatoid arthritis disease, Crohn's disease, Hodgkin's lymphoma, colorectal cancer, rheumatoid arthritis, respiratory syncytial virus, colon cancer, and others.
Company Facts
- Founded: 2002
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 1,001 – 5,000
- Estimated revenue: $1M – $10M
- Funding stage: IPO
- Last round: Post-IPO Equity (Jan 2006)
- Ticker: kosdaq:068270
- Website: celltrion.com
- Phone: +82328505000
Industries & Categories
Biotechnology, Health Care, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/celltrion-11127 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.